id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-E-0525-0003,FDA,FDA-2002-E-0525,FDA/CDER to the USPTO - Letter,Other,LET-Letter,2002-11-05T05:00:00Z,2002,11,,,2008-07-17T19:38:07Z,,0,0,09000064804a5765
FDA-2002-E-0525-0001,FDA,FDA-2002-E-0525,USPTO to FDA/CDER - Letter,Other,LET-Letter,2002-04-16T04:00:00Z,2002,4,,,2008-07-17T19:29:37Z,,0,0,09000064804a5758
FDA-2002-E-0525-0002,FDA,FDA-2002-E-0525,USPTO to FDA/CDER - Letter,Other,LET-Letter,2002-04-16T04:00:00Z,2002,4,,,2008-07-17T19:32:23Z,,0,0,09000064804a5764